Another study showed that triacylglycerol, but not cholesterol, was selected as the main serum lipid used to distinguish PD patients from leucine-rich repeat kinase 2 (LRRK2) mutation carriers (Galper et al., 2022). This evidence concerns the gene LRRK2 and Parkinson disease.